Dublin, April 30, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/6d85l6/biological_safety) has announced the addition of the "Biological Safety Testing Market by Application (Stem Cell, Blood, Gene Therapy), Product (Instruments, Services, Kits, Reagents), & Test (Bioburden, Endotoxin, Cell Line Authentication, Residual Contamination, Adventitious Agents) - Global Forecast to 2019" report to their offering.
The global biologics safety testing market was valued at $1,758.69 million in 2014 and is expected to grow at a CAGR of 12.23% to reach $3,130.85 million by 2019
Biologics are products made from plants, animals, or microorganisms. Biological safety testing is an important and mandatory aspect as these products are used for treatment and diagnostic purposes in humans. The market for these products is flourishing as the demand for these medicines, driven by the growth of the global disease burden, is increasing. In addition, the number of pharmaceutical and biotechnology firms has also risen in recent years to cater to the growing demand for medicines. This aids the growth of the biologics safety testing market.
This report segments the global biologic safety testing market based on product, type of test, application, and geography. The product segments included in the report are instruments, kits & reagents, and services. Based on test, this market is categorized into adventitious agents detection tests, bioburden tests, cell line authentication and characterization tests, endotoxin tests, residual host contaminant detection tests, sterility testing, and other tests (efficacy tests, toxicity tests, stability tests). The application segments included in the report are blood & blood products, cellular & gene therapy products, stem cell products, tissues & tissue products, and vaccines and therapeutics. Based on geography, the biological safety testing market is segmented into North America, Europe, Asia, and the Rest of the World (RoW).
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Biologics Safety Testing Market, By Application
8 Biologics Safety Testing Market, By Product
9 Biologics Safety Testing Market, By Tests
10 Geographic Analysis
11 Competitive Landscape
12 Company Profiles
- Avance Biosciences Inc.
- Bsl Bioservice
- Charles River Laboratories International, Inc.
- Cytovance Biologics, Inc.
- Lonza Group
- Merck & Co., Inc.
- SGS S.A.
- Sigma-Aldrich Corporation
- Toxikon Corporation
- Wuxi Pharmatech (Cayman) Inc.
For more information visit http://www.researchandmarkets.com/research/6d85l6/biological_safety